Author of the publication

Immunoblastic morphology but not the immunohistochemical GCB/nonGCB classifier predicts outcome in diffuse large B-cell lymphoma in the RICOVER-60 trial of the DSHNHL

, , , , , , , , , , , , , , , , , , , , , and . Blood, 116 (23): 4916–4925 (2010)

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed. You can also use the button next to the name to display some publications already assigned to the person.

 

Other publications of authors with the same name

Microarray-based genomic profiling reveals novel genomic aberrations in follicular lymphoma which associate with patient survival and gene expression status, , , , , , , , , and 18 other author(s). Genes, chromosomes & cancer, 48 (1): 39–54 (2009)Loss of HLA-DR expression and immunoblastic morphology predict adverse outcome in diffuse large B-cell lymphoma - analyses of cases from two prospective randomized clinical trials, , , , , , , , , and 10 other author(s). Haematologica, 94 (11): 1569–1580 (2009)Immunoblastic morphology but not the immunohistochemical GCB/nonGCB classifier predicts outcome in diffuse large B-cell lymphoma in the RICOVER-60 trial of the DSHNHL, , , , , , , , , and 12 other author(s). Blood, 116 (23): 4916–4925 (2010)New insights into the biology and origin of mature aggressive B-cell lymphomas by combined epigenomic, genomic, and transcriptional profiling, , , , , , , , , and 33 other author(s). Blood, 113 (11): 2488–2497 (2009)A biological definition of Burkitt's Lymphoma from transcriptional and genomic profiling, , , , , , , , , and 25 other author(s). The New England Journal of Medicine, 354 (23): 2419--2430 (2006)Biological characterization of adult MYC-translocation-positive mature B-cell lymphomas other than molecular Burkitt lymphoma, , , , , , , , , and 13 other author(s). Haematologica, 99 (4): 726–735 (2014)A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling, , , , , , , , , and 25 other author(s). The New England journal of medicine, 354 (23): 2419–2430 (2006)MYC status in concert with BCL2 and BCL6 expression predicts outcome in diffuse large B-cell lymphoma, , , , , , , , , and 10 other author(s). Blood, 121 (12): 2253–2263 (2013)Gain of chromosome region 18q21 including the MALT1 gene is associated with the activated B-cell-like gene expression subtype and increased BCL2 gene dosage and protein expression in diffuse large B-cell lymphoma, , , , , , , , , and 9 other author(s). Haematologica, 93 (5): 688–696 (2008)Molecular profiling of pediatric mature B-cell lymphoma treated in population-based prospective clinical trials, , , , , , , , , and 10 other author(s). Blood, 112 (4): 1374–1381 (2008)